UBS maintains Sanofi at Neutral

UBS maintains Sanofi at Neutral
Credit: © Reuters.

An UBS analyst maintained Sanofi (EPA: SASY) at Neutral and a price target of $100.00 from a prior price target of EUR93.00.

Prior to this rating, Sanofi had 16 buy ratings, 7 hold ratings, and 0 sell ratings.

For consensus analyst estimates and price targets on Sanofi, click here. For more news on Sanofi, click here.

Sanofi's stock price closed at $101.00. They are up 14.32% in the last month and up 9.64% in the last 12 months.

According to Investing Pro, Sanofi's fair value is $132.72, an upside of 32.72%. Sanofi's fair value comes with a low degree of uncertainty, according to InvestingPro.

Check out Sanofi's recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or